Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to the requirement of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby enclose the certificate received from our Share Transfer Agent viz. Bigshare Services Private Limited for the quarter ended on 31st March, 2021. This is for your information and record. Earum Pharmaceuticals Ltd - 542724 - Shareholding for the Period Ended March 31, 2021
Earum Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RONAK NARENDRA LALWANIDesignation :- Company Secretary and Compliance Officer Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to the requirement of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby enclose the certificate received from our Share Transfer Agent viz. Bigshare Services Private Limited for the quarter ended on 31st December, 2020. This is for your information and record. Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RONAK NARENDRA LALWANIDesignation :- Company Secretary and Compliance Officer Earum Pharmaceuticals Ltd - 542724 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Earum Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Earum Pharmaceuticals Ltd - 542724 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In terms of the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the results of the voting conducted through Ballot Papers at the 08th Annual General Meeting of Earum Pharmaceuticals Limited held on December 30, 2020 along with Scrutinizer report. We request you to take the voting results on records. Earum Pharmaceuticals Ltd - 542724 - Shareholder Meeting / Postal Ballot-Outcome of AGM
It is hereby informed that the 08th Annual General Meeting of the Company held on Wednesday, the 30th day of December, 2020 at 03:00 P.M. at the Corporate Office of the Company at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat -380060 and the business mentioned in the notice were duly transacted. In this regard please find herewith enclosed proceeding of the 08th Annual General Meeting (AGM) in terms of Regulation 29 read with Para A of Schedule III of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015. You are requested to kindly take the same on record. Earum Pharmaceuticals Ltd - 542724 - Notice Of The 8Th AGM
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 & Section 96 of the Companies Act, 2013 and other applicable provisions of Companies Act, 2013, we would like to inform you that the 8th Annual General Meeting of the Company would be held on 30th December 2020 at 03:00 P.M. at the Corporate Office of the Company at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat -380060. Further, pursuant to Section 108 of the Companies Act, 2013 read with Proviso to rule 20{2} of Companies (Management and Administration} Rules. 2014, as amended, the Board is of opinion that the company being listed on SME Platform of BSE, specific exemption from e-voting facility should be claimed and thus have resolved not to provide e-voting facility for the ensuing AGM. We enclose herewith the Notice of 8th Annual General Meeting along with Proxy form, attendance slip containing the requisite details.